Jane Street Group, LLC Hookipa Pharma Inc. Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.59 - $1.04 $5,451 - $9,609	9,240 Added 35.54%	35,242 $20,000
Q1 2024 May 15, 2024	BUY	$0.61 - $0.83 $15,861 - $21,581	26,002 New	26,002 $18,000
Q1 2023 May 15, 2023	SELL	$0.72 - $1.03 $15,971 - $22,848	-22,183 Reduced 42.18%	30,408 $22,000
Q4 2022 Feb 14, 2023	BUY	$0.73 - $14.6 $38,391 - $767,828	52,591 New	52,591 $42,000
Q4 2021 Feb 15, 2022	SELL	$2.33 - $5.94 $25,613 - $65,298	-10,993 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$5.89 - $9.35 $64,748 - $102,784	10,993 New	10,993 $64,000
Q3 2020 Nov 17, 2020	SELL	$8.59 - $11.89 $101,035 - $139,850	-11,762 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$7.23 - $12.1 $85,039 - $142,320	11,762 New	11,762 $137,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.